Please Wait.....
Report
Global Spatial Genomics and Transcriptomics Market
Market Research Report I 2023-03-07 I 157 Pages I BCC Research
Description
Report Scope:
This report incorporates an in-depth analysis of the spatial genomics and transcriptomics market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The product analysis focuses on recent technological trends in various regions, such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for spatial genomics and transcriptomics technologies.
The scope of the report covers only those spatial genomics and transcriptomics technologies that generate the most global revenue. Spatial genomics and transcriptomics are similar to spatial biology.
This report segments the global market by the geographic regions of North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data are provided for 2021 as the base year and forecast through the end of 2027.
Report Includes:
- 34 data tables and 30 additional tables
- An overview of the global spatial genomics and transcriptomics market
- Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the market size and highlights of the market potential by technology, end user, and application
- Detailed description of fluorescence In situ hybridization and microscopy RNA imaging and discussion on their application in the genomics industry
- Assessment of the current market size and forecast of market development in the coming five years, and insight into the value chain analysis, and factors driving and restraining the growth
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global spatial genomics and transcriptomics market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
- Company profiles of the leading global players, including Advanced Cell Diagnostics Inc., Bruker, Illumina, Standard BioTools Inc., Vizgen and Lunaphore
Executive Summary
Summary:
The global market for spatial genomics and transcriptomics market was valued at $REDACTED billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach approximately $REDACTED billion by the end of 2027.
The high growth rate of this segment is attributed to factors such as the demand of antibody research, the expanding COVID-19 pandemic, epidemics of other infectious diseases and an increase in R&D activities by key companies to develop new data regarding genetic consequences to counter the global rise in different infectious diseases. The advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies and usage of different spatial genomics and transcriptomics instruments. Fulgent Genetics Inc., a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health,
announced a strategic investment in Spatial Genomics Inc. a leading developer of sequential fluorescence in situ hybridization (seqFISH) technology. Fulgent Genetics is investing up to $REDACTED million tolead Spatial Genomics' Series A financing. This includes investments by 12 West Capital and otherinvestors. The company developed tests for COVID-19 and genetic testing, and it continues to developnew tests that are attractive to its various customer markets.
Spatial genomics and transcriptomics are growing at a high rate due to its advantages in genetic mapping, understanding of locations of infection genes and understanding of drug adaption according to the genetic module of disease. Demand for biomarkers for cancer, drugs for neurology diseases and the COVID-19 pandemic are also likely to propel market growth.
Technological advances in medical devices impacts most therapeutic areas. The largest user segments are tissue engineering, drug discovery and regenerative medicine. According to the World Health Organization (WHO), more than REDACTED children develop cancer each year. Cancer accounted for nearly REDACTED million deaths in 2020. Spatial genomics and transcriptomics could help clinicians and patientseliminate the list of requirements for drugs or therapies by shortening the spatial biology R&D process.
Fluorescence in situ hybridization has the advantages of locating the specific DNA sequences, diagnoses of genetic diseases, gene mapping and identification of novel oncogenes or genetic aberrations contributing to various types of cancers. Advances in FISH techniques has also increased the demand for genomic in situ hybridization (GISH) and new probes locus specific or whole chromosome probes.
The market for sequencing techniques was estimated at $REDACTED million in 2021, and at a CAGR of REDACTED% it is expected to reach $REDACTED million by the end of 2027.This most widely used technologies in the genomics toolbox are bulk RNA sequencing (RNAseq), popular single cell RNA sequencing (scRNAseq) and newly emerged spatial RNA sequencing (spRNAseq). Sequencing is one of the most widely used technologies for genomic study.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst's Credentials
1.8 BCC Custom Research
1.9 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Spatial Genomics and Transcriptomics
3.1.1 Spatial Genomics
3.1.2 Spatial Transcriptomics
3.2 Spatial Transcriptomics Technologies
3.2.1 Fusion of Multiple Technologies
3.2.2 Spatial Genomics and Transcriptomics Provides Balance
3.3 Understanding Spatial Biology
3.4 Importance of Spatial Biology
3.5 Spatial Sequencing
3.6 Spatial Biology of Cancer Evolution
3.7 Innovation in Medical and Healthcare Products
3.8 Current Trends
3.8.1 Enhanced Cybersecurity
3.8.2 Internet of Medical Things
3.8.3 Medical Robots
3.8.4 Three-Dimensionally Printed Objects
3.8.5 Device Connectivity
3.8.6 Implications for Health Systems
3.9 Regulations and Legislation
3.9.1 Europe
3.9.2 U.S.
3.9.3 Japan
Chapter 4 Market Dynamics
4.1 Drivers
4.1.1 New Discoveries in Biological Sciences
4.1.2 Increasing Use of Bioinformatics Analytical Software
4.1.3 Antibody-Based Drug Discovery and Development
4.1.4 Developed and Increasing Research Areas
4.1.5 Application-Focused Technology Platforms
4.1.6 Strengthen Use and Adoption of Consumables
4.1.7 Increase in Infectious and Chronic Diseases
4.1.8 Relationships among Biopharma Firms, Research Institutions and Medical Centers
4.2 Restraints
4.2.1 Labor-Intensive Technology and Products
4.3 Opportunities
4.3.1 Human Genome Project Development
4.3.2 Coming Revolution of Precision Medicine
4.4 Strategies
4.4.1 Trends
Chapter 5 Impact of the COVID-19 Pandemic
5.1 Impact of COVID-19 on Pharmaceutical and Biotech Industries
5.2 Short-Term Impact
5.2.1 Change in Demand
5.2.2 Shift of Communication and Promotions to Remote Interactions
5.2.3 Changes in R&D
5.3 Long-Term Impact
5.3.1 Delayed Approvals for Non-COVID-Related Pharmaceutical and Biotech Products
5.3.2 Self-Sufficiency in the Pharma and Biotech Industries
5.3.3 Pharmaceutical Industry Growth Slowdown
5.3.4 Changes in Consumption Trends in Health-Related Products
5.3.5 Potential Impact of COVID-19 on Genomic Study
Chapter 6 Business Model and Innovation
6.1 Business Model Innovation
Chapter 7 Global Spatial Genomics and Transcriptomics: Technology Market
7.1 Overview
7.2 Spatial Genomics
7.2.1 Market Outlook
7.3 Spatial Transcriptomics
7.3.1 Market Outlook
Chapter 8 Global Spatial Genomics and Transcriptomics Market by Product
8.1 Overview
8.2 Market for Spatial Genomics and Transcriptomics, by Product
8.3 Market Outlook
8.3.1 Consumables
8.3.2 Instruments
8.3.3 Software
Chapter 9 Global Spatial Genomics and Transcriptomics Market by Application
9.1 Overview
9.2 Spatial Genomics and Transcriptomics Market by Application
9.3 Market Outlook
9.3.1 Clinical and Translational Research
9.3.2 Drug Discovery and Development
Chapter 10 Global Spatial Genomics and Transcriptomics Market by End User
10.1 Overview
10.2 Market for Spatial Genomics and Transcriptomics by End User
10.3 Market Outlook
10.3.1 Academic and Research Institutes
10.3.2 Contract Research Organizations
10.3.3 Pharmaceutical and Biotechnology
Chapter 11 Global Spatial Genomics and Transcriptomics Market by Region
11.1 North America
11.1.1 Market Outlook
11.2 Europe
11.2.1 Market Outlook
11.3 Asia-Pacific
11.3.1 Market Outlook
11.4 Rest of the World
11.4.1 Market Outlook
Chapter 12 Competitive Landscape
Chapter 13 Company Profiles
10X GENOMICS
ADVANCED CELL DIAGNOSTICS INC.
AKOYA BIOSCIENCES INC.
BRUKER CORP.
DOVETAIL GENOMICS (CANTATA BIO)
ILLUMINA
IONPATH INC.
LUNAPHORE TECHNOLOGIES S.A.
NANOSTRING TECHNOLOGIES
RARECYTE INC.
STANDARD BIOTOOLS INC.
VIZGEN INC.
Other Companies
List of Tables
Summary Table : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 1 : Differences Between Single-Cell RNA-Seq and RNA-Seq
Table 2 : Class I and II Exempt Devices
Table 3 : Akoya's Relationship with Universities and Organizations
Table 4 : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 5 : Global Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 6 : Global Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 7 : Global Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 8 : Global Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 9 : Global Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 10 : North American Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 11 : North American Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 12 : North American Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 13 : North American Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 14 : North American Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 15 : North American Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 16 : North American Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 17 : European Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 18 : European Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 19 : European Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 20 : European Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 21 : European Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 22 : European Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 23 : European Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 24 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 25 : Asia-Pacific Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 26 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 27 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 28 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 29 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 30 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 31 : RoW Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
Table 32 : RoW Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
Table 33 : RoW Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
Table 34 : RoW Spatial Genomics and Transcriptomics Market, by Product, Through 2027
Table 35 : RoW Spatial Genomics and Transcriptomics Market, by Application, Through 2027
Table 36 : RoW Spatial Genomics and Transcriptomics Market, by End User, Through 2027
Table 37 : RoW Spatial Genomics and Transcriptomics Market, by Country, Through 2027
Table 38 : Recent Company News, 2022
Table 39 : 10xGenomics: Product Portfolio
Table 40 : 10xGenomics: Recent Developments, 2020-2022
Table 41 : Advanced Cell Diagnostics Inc.: Product Portfolio
Table 42 : Advanced Cell Diagnostics Inc.: Recent Developments, 2019-2023
Table 43 : Akoya Biosciences Inc.: Product Portfolio
Table 44 : Akoya Biosciences Inc.: Recent Developments, 2020-2022
Table 45 : Bruker: Product Portfolio
Table 46 : Bruker: Recent Developments, 2021-2023
Table 47 : Dovetail Genomics: Product Portfolio
Table 48 : Dovetail Genomics: Recent Developments, 2019-2022
Table 49 : Illumina: Product Portfolio
Table 50 : Illumina: Recent Developments, 2020-2023
Table 51 : Ionpath Inc.: Product Portfolio
Table 52 : Ionpath Inc.: Recent Developments, 2020-2022
Table 53 : Lunaphore: Product Portfolio
Table 54 : Lunaphore: Recent Developments, 2022
Table 55 : NanoString: Product Portfolio
Table 56 : NanoString: Recent Developments, 2020-2022
Table 57 : RareCyte: Product Portfolio
Table 58 : RareCyte: Recent Developments, 2021 and 2022
Table 59 : Standard BioTools Inc.: Product Portfolio
Table 60 : Standard BioTools Inc.: Recent Developments, 2019-2022
Table 61 : Vizgen: Product Portfolio
Table 62 : Vizgen: Recent Developments, 2021-2023
Table 63 : Other Spatial Genomics and Transcriptomics Startups
List of Figures
Summary Figure : Global Market for Spatial Genomics and Transcriptomics, by Genomics Technologies, 2019-2027
Figure 1 : Spatial Transcriptomics Results from Fusion of Multiple Technologies
Figure 2 : U.S. Medical Device Marketing Process
Figure 3 : Global Projected Diabetes Incidence, Patients Age 20-79, 2010 and 2030
Figure 4 : Global Infectious Diseases Incidence, Between 2020 and 2022
Figure 5 : Global Infectious Diseases Outbreak, 2022
Figure 6 : Impact of COVID-19 on the Pharmaceutical and Biotech Industries
Figure 7 : Business Models' Five Interconnected Components
Figure 8 : Lead Gears Drive the Business Model Shift
Figure 9 : Global Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 10 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
Figure 11 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Transcriptomics, 2021
Figure 12 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 13 : Global Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 14 : Growth of Multi-Omics in Different End Users
Figure 15 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 16 : North American Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 17 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
Figure 18 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
Figure 19 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 20 : North American Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 21 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 22 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 23 : U.S. Population Age 65 or Older, 2010-2050
Figure 24 : European Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 25 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technologies, 2021
Figure 26 : Figure 26 European Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
Figure 27 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 28 : European Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 29 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 30 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 31 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 32 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
Figure 33 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
Figure 34 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 35 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 36 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 37 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 38 : RoW Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
Figure 39 : RoW Spatial Genomics and Transcriptomics Market Shares, by Genomics Technology, 2021
Figure 40 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Transcriptomics, 2021
Figure 41 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
Figure 42 : RoW Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
Figure 43 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
Figure 44 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
Figure 45 : Ranking of Spatial Genomics and Transcriptomics Companies, 2021
Figure 46 : Ranking of Spatial Genomics and Transcriptomics Private Companies, 2021
Figure 47 : 10xGenomics: Annual Revenue, 2019-2021
Figure 48 : 10xGenomics: Revenue Share, by Business Segment, 2021
Figure 49 : 10xGenomics: Revenue Share, by Region, 2021
Figure 50 : Bio-Techne: Annual Revenue, 2020-2022
Figure 51 : Bio-Techne: Revenue Share, by Business Segment, 2021
Figure 52 : Akoya Biosciences Inc.: Annual Revenue, 2020 and 2021
Figure 53 : Akoya Biosciences Inc.: Revenue Share, by Business Segment, 2021
Figure 54 : Bruker: Annual Revenue, 2019-2021
Figure 55 : Bruker: Revenue Share, by Business Segment, 2021
Figure 56 : Illumina: Annual Revenue, 2019-2021
Figure 57 : Illumina: Revenue Share, by Business Segment, 2021
Figure 58 : NanoString: Annual Revenue, 2019-2021
Figure 59 : NanoString: Revenue Share, by Business Segment, 2021
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security